Search results
Showing 61 to 75 of 164 results for metastatic breast cancer
Find out about the progress made by the health and care system in implementing NICE guidance on prostate cancer
In development [GID-TA11514] Expected publication date: 25 September 2024
Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults.
Awaiting development [GID-TA11342] Expected publication date: TBC
Breast cancer (locally advanced or metastatic) - ixabepilone [ID377]
Discontinued [GID-TAG403]
Awaiting development [GID-TA11273] Expected publication date: TBC
Awaiting development [GID-TA11519] Expected publication date: TBC
In development [GID-TA11546] Expected publication date: 10 September 2025
Awaiting development [GID-TA11231] Expected publication date: TBC
This guideline covers the diagnosis and management of menopause, including in women who have premature ovarian insufficiency. The guideline aims to improve the consistency of support and information provided to women in menopause.
This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.
Capivasertib with paclitaxel for untreated metastatic triple-negative breast cancer [ID6383]
Awaiting development [GID-TA11411] Expected publication date: TBC